Long-term treatment with tralokinumab normalizes the molecular gene signature of atopic dermatitis

被引：0
|
作者：
Guttman-Yassky, E.
Pavel, A.
Kabashima, K.
Staumont-Salle, D.
Eyerich, K.
Nahm, W.
Pauser, S.
Da Rosa, J. Correa
Ropke, M.
Amoudruz, P.
Blauvelt, A.
Reich, K.
机构：
来源：
ALLERGY AND ASTHMA PROCEEDINGS | 2022年 / 43卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：567 / 567
页数：1
相关论文
共 50 条
  • [1] Long-term treatment with tralokinumab normalizes the molecular gene signature of atopic dermatitis
    Guttman-Yassky, E.
    Pavel, A.
    Kabashima, K.
    Staumont-Salle, D.
    Eyerich, K.
    Nahm, W.
    Pauser, S.
    Da Rosa, J. Correa
    Roepke, M.
    Amoudruz, P.
    Schneider, S.
    Blauvelt, A.
    Reich, K.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E146 - E147
  • [2] Long-term treatment with tralokinumab normalizes the molecular gene signature of atopic dermatitis
    Guttman-Yassky, E.
    Pavel, A.
    Kabashima, K.
    Staumont-Salle, D.
    Eyerich, K.
    Nahm, W.
    Pauser, S.
    Da Rosa, J. C.
    Roepke, M.
    Amoudruz, P.
    Blauvelt, A.
    Reich, K.
    EXPERIMENTAL DERMATOLOGY, 2021, 30 : 27 - 28
  • [3] Long-term tralokinumab therapy in moderate to severe atopic dermatitis
    Lorenz, Judith
    AKTUELLE DERMATOLOGIE, 2023, 49 (03) : 91 - 91
  • [4] Long-Term Treatment of Atopic Dermatitis
    Prezzano, James C.
    Beck, Lisa A.
    DERMATOLOGIC CLINICS, 2017, 35 (03) : 335 - +
  • [5] LONG-TERM EFFICACY OF TRALOKINUMAB IN ADOLESCENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
    Wollenberg, Andreas
    Paller, Amy S.
    Bewley, Anthony
    Cork, Michael
    Hong, Chih-Ho
    Soong, Weily
    Oland, Christian Bjerregard
    Taveira, Christian Moreira
    Gjerum, Le
    Blauvelt, Andrew
    ACTA DERMATO-VENEREOLOGICA, 2023, 103 : 54 - 54
  • [6] Tralokinumab for the Treatment of Atopic Dermatitis
    Egídio Freitas
    Emma Guttman-Yassky
    Tiago Torres
    American Journal of Clinical Dermatology, 2021, 22 : 625 - 638
  • [7] Tralokinumab for the Treatment of Atopic Dermatitis
    Freitas, Egidio
    Guttman-Yassky, Emma
    Torres, Tiago
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2021, 22 (05) : 625 - 638
  • [8] Review of Tralokinumab in the Treatment of Atopic Dermatitis
    Singh, Rohan
    Taylor, Alexandra
    Shah, Milaan A.
    Strowd, Lindsay C.
    Feldman, Steven R.
    ANNALS OF PHARMACOTHERAPY, 2023, 57 (03) : 333 - 340
  • [9] EADV: New long-term data up to 4 years highlight the important role of Adtralza (tralokinumab) as a long-term treatment option for atopic dermatitis
    不详
    ALLERGOLOGIE, 2023, 46 (12) : 837 - 838
  • [10] Stability of long-term therapeutic responses to tralokinumab in adults with moderate-to-severe atopic dermatitis
    Blauvelt, Andrew
    Hong, H. Chih-ho
    Peris, Ketty
    Katoh, Norito
    Tauber, Marie
    Ameen, Mahreen
    Gooderham, Melinda
    Oland, Christian Bjerregard
    Tindberg, Ann-Marie
    Gjerum, Le
    Reich, Kristian
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 : 30 - 31
12345